Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 252.50
-3.10 (-1.21%)
At close: Aug 17, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 110.21 billion as of August 17, 2026. Its market cap has increased by 151.40% in one year.
Market Cap
110.21B
Enterprise Value
114.55B
Revenue
35.75B
Ranking
n/a
PE Ratio
53.18
Stock Price
252.50
ChartMarket Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 110.21B, an increase of 31,591.42%. That is a compound annual growth rate of 30.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 110.21B | 21.51% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 268.01B |
| Granules India | 212.63B |
| AstraZeneca Pharma India | 193.84B |
| Caplin Point Laboratories | 188.55B |
| Jubilant Pharmova | 136.92B |
| CORONA Remedies | 130.71B |
| Procter & Gamble Health | 98.50B |
| Sanofi India | 74.77B |